- Home
- ANGO vs NEN Comparison
ANGO vs NEN Comparison
Compare ANGO & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGO
- NEN
- Stock Information
- Founded
- ANGO 1988
- NEN 1977
- Country
- ANGO United States
- NEN United States
- Employees
- ANGO N/A
- NEN N/A
- Industry
- ANGO Medical/Dental Instruments
- NEN Building operators
- Sector
- ANGO Health Care
- NEN Real Estate
- Exchange
- ANGO Nasdaq
- NEN Nasdaq
- Market Cap
- ANGO 279.1M
- NEN 282.1M
- IPO Year
- ANGO 2004
- NEN N/A
- Fundamental
- Price
- ANGO $8.86
- NEN $80.19
- Analyst Decision
- ANGO Strong Buy
- NEN
- Analyst Count
- ANGO 4
- NEN 0
- Target Price
- ANGO $12.00
- NEN N/A
- AVG Volume (30 Days)
- ANGO 615.8K
- NEN 121.0
- Earning Date
- ANGO 01-08-2025
- NEN 01-01-0001
- Dividend Yield
- ANGO N/A
- NEN 1.99%
- EPS Growth
- ANGO N/A
- NEN 67.91
- EPS
- ANGO N/A
- NEN 3.91
- Revenue
- ANGO $292,726,000.00
- NEN $81,169,352.00
- Revenue This Year
- ANGO N/A
- NEN N/A
- Revenue Next Year
- ANGO $7.69
- NEN N/A
- P/E Ratio
- ANGO N/A
- NEN $20.63
- Revenue Growth
- ANGO N/A
- NEN 10.81
- 52 Week Low
- ANGO $5.26
- NEN $67.04
- 52 Week High
- ANGO $9.58
- NEN $84.00
- Technical
- Relative Strength Index (RSI)
- ANGO 61.62
- NEN 38.67
- Support Level
- ANGO $8.45
- NEN $82.10
- Resistance Level
- ANGO $9.58
- NEN $82.74
- Average True Range (ATR)
- ANGO 0.49
- NEN 0.08
- MACD
- ANGO 0.05
- NEN -0.29
- Stochastic Oscillator
- ANGO 65.79
- NEN 0.00
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.